Close Menu


The small grants will fund biomarker studies, molecular science, and diagnostic research into immunodeficiency diseases.

The $20 million program will support development of tools for NIAID priorities including diagnostics, therapeutics, vaccines, and others.

The schools will use the NIAID grant to expand the Eukaryotic Pathogen Genome Database Resource for five years.

While the system will provide a level of multiplexing that is "more than conventional PCR, but not as high as microarrays in general," the expected cost "is on par with, and in some respects lower than, what hospitals and clinics are paying for real-time PCR."

The institutes have a working group that will review new candidate pathogens and invertebrate disease vectors for the sequencing centers.

The company will use the NIAID funding to develop its synthetic biology technologies.

The Bioinformatics Resource Center will be one of four, under a $67.5 million NIAID program.

The stimulus funding will support centers for wide-ranging studies of the human immune system.

The company will use an SBIR and an STTR grant to develop POC tests for HIV and respiratory diseases.

The grants will support studies of a gene complex associated with immune-mediated diseases.


The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.

The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.

New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.

In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.